Home/Filings/4/0001437749-21-022212
4//SEC Filing

Horvath Susan 4

Accession 0001437749-21-022212

CIK 0001029125other

Filed

Sep 14, 8:00 PM ET

Accepted

Sep 15, 5:59 PM ET

Size

5.1 KB

Accession

0001437749-21-022212

Insider Transaction Report

Form 4
Period: 2021-09-13
Horvath Susan
V.P. of Finance & CFO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-09-13+12,13512,135 total
    Exercise: $2.26Exp: 2031-09-13Common Stock (12,135 underlying)
Footnotes (1)
  • [F1]The stock option is schedule to vest in three equal annual installments on September 13, 2022, 2023 and 2024.

Issuer

Panbela Therapeutics, Inc.

CIK 0001029125

Entity typeother

Related Parties

1
  • filerCIK 0001322846

Filing Metadata

Form type
4
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 5:59 PM ET
Size
5.1 KB